Sexual Dysfunction (Medication-Induced) Secondary to PTSD (Treated with SSRIs/SNRIs or Antipsychotics)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Sexual Dysfunction (Medication-Induced) is a documented secondary pairing for PTSD (Treated with SSRIs/SNRIs or Antipsychotics) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Sexual Dysfunction (Medication-Induced) separately under its own 38 CFR Part 4 diagnostic code, then combines it with PTSD (Treated with SSRIs/SNRIs or Antipsychotics) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Sexual Dysfunction (Medication-Induced) as secondary to PTSD (Treated with SSRIs/SNRIs or Antipsychotics) is rated strong. Sexual dysfunction — including delayed ejaculation, anorgasmia, reduced libido, and erectile dysfunction — is among the most common and persistent adverse effects of SSRI and SNRI antidepressants prescribed for PTSD. Reported rates of SSRI-induced sexual dysfunction range from 30–70% in systematically assessed cohorts. Mechanism: SSRIs increase serotonin in the hypothalamus, which tonically inhibits dopaminergic pathways via 5-HT2A and 5-HT3 receptors; dopamine is the primary neurotransmitter driving sexual desire and orgasm. SNRI-induced noradrenergic enhancement further inhibits sexual response via alpha-adrenergic vasoconstriction of genitourinary smooth muscle. Antipsychotics used for PTSD (quetiapine, risperidone, olanzapine) cause hyperprolactinemia via D2 receptor blockade, suppressing testosterone and libido. Under 38 CFR § 3.310, medication-side-effect-caused conditions are compensable as secondary to the condition requiring the medication.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.